Literature DB >> 10093068

Can alpha-immunotherapy succeed where other systemic modalities have failed?

B J Allen.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10093068

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN： 0143-3636            Impact factor:   1.690


× No keyword cloud information.
  10 in total

Review 1.  The potential complementary role of targeted alpha therapy in the management of metastatic melanoma.

Authors:  Michael P Brown; Eva Bezak; Barry J Allen
Journal:  Melanoma Manag       Date:  2015-11-24

Review 2.  Imaging in targeted delivery of therapy to cancer.

Authors:  Gairin Dancey; Richard H Begent; Tim Meyer
Journal:  Target Oncol       Date:  2009-10-08       Impact factor: 4.493

3.  Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab.

Authors:  G-J Beyer; M Miederer; S Vranjes-Durić; J J Comor; G Künzi; O Hartley; R Senekowitsch-Schmidtke; D Soloviev; F Buchegger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

4.  Pre-clinical study of 213Bi labeled PAI2 for the control of micrometastatic pancreatic cancer.

Authors:  Chang F Qu; Emma Y Song; Yong Li; Syed M A Rizvi; Chand Raja; Ross Smith; Alfred Morgenstern; C Apostolidis; Barry J Allen
Journal:  Clin Exp Metastasis       Date:  2006-02-11       Impact factor: 5.150

5.  MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugate.

Authors:  C F Qu; Y Li; Y J Song; S M A Rizvi; C Raja; D Zhang; J Samra; R Smith; A C Perkins; C Apostolidis; B J Allen
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

6.  213Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model.

Authors:  Y Li; S M A Rizvi; M Ranson; B J Allen
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

Review 7.  Targeted alpha anticancer therapies: update and future prospects.

Authors:  Barry J Allen; Chen-Yu Huang; Raymond A Clarke
Journal:  Biologics       Date:  2014-11-10

Review 8.  Systemic targeted alpha radiotherapy for cancer.

Authors:  Bj Allen
Journal:  J Biomed Phys Eng       Date:  2013-09-17

9.  Targeted alpha therapy approach to the management of pancreatic cancer.

Authors:  Barry J Allen; Syed M Abbas Rizvi; Chang F Qu; Ross C Smith
Journal:  Cancers (Basel)       Date:  2011-04-01       Impact factor: 6.639

10.  Preclinical studies of targeted alpha therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2.

Authors:  B J Allen; Z Tian; S M A Rizvi; Y Li; M Ranson
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.